AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (February 12, 2008). doi:10.1152/ajpendo.00653.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/5/E841    most recent
00653.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Westerbacka, J.
Right arrow Articles by Yki-Jarvinen, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Westerbacka, J.
Right arrow Articles by Yki-Jarvinen, H.
Submitted on November 30, 2006
Accepted on December 27, 2007

INSULIN REGULATION OF MCP-1 IN HUMAN ADIPOSE TISSUE OF OBESE AND LEAN WOMEN

Jukka Westerbacka1*, Anja Corner2, Maria Kolak3, Janne Makkonen1, Ursula Turpeinen4, Anders Hamsten3, Rachel M Fisher3, and Hannele Yki-Jarvinen5

1 Department of Medicine, Division of Diabetes, University of Helsinki, Helsinki, Finland; Minerva Foundation Institute for Medical Research, Helsinki, Finland
2 Department of Medicine, Division of Diabetes, University of Helsinki, Helsinki, Finland
3 Atherosclerosis Research Unit, King Gustaf V Research Institute, Karolinska Institutet, Stockholm, Sweden
4 Helsinki University Central Hospital, HUSLAB, Finland
5 Department of Medicine, Division of Diabetes, University of Helsinki, Helsinki, Finland; Atherosclerosis Research Unit, King Gustaf V Research Institute, Karolinska Institutet, Stockholm, Sweden

* To whom correspondence should be addressed. E-mail: jukka.westerbacka{at}helsinki.fi.

Objective: CCL2 (MCP-1, monocyte chemoattractant protein 1) and CCL3 (MIP-1{alpha}, macrophage inflammatory protein 1{alpha}) are required for macrophage infiltration in adipose tissue. Insulin increases CCL2 expression in adipose tissue and serum more in insulin-resistant obese than in insulin-sensitive lean mice but whether this is true in humans is unknown. Research Methods and Procedures: Subcutaneous adipose tissue biopsies and blood samples were obtained before and at the end of 6 hours of in vivo euglycemic hyperinsulinemia (insulin clamp technique) in 11 lean insulin-sensitive and 10 obese insulin-resistant women, and before and after a 6-hour saline infusion in 8 women. Adipose tissue mRNA concentrations of monocyte/macrophage markers CD68, EMR1, ITGAM, ADAM8, and CCL2 and CCL3, and housekeeping gene RPLP0 were measured using real-time PCR at baseline. Expression of CCL2, CCL3 and RPL0 were measured also after insulin infusion. Serum levels of MCP-1 and MIP-{alpha} and protein concentration of MCP-1 in adipose tissue were determined at baseline and after insulin infusion. Results: Basally, expression of the macrophage markers CD68 and EMR1 were increased in adipose tissue of insulin-resistant subjects. Insulin increased MCP-1 gene and protein expressionsignificantly more in the insulin-resistant than in the insulin-sensitive subjects. Basally expression of CCL2 and CCL3 and expression of macrophage markers CD68 and ITGAM were significantly correlated. In serum, MCP-1 decreased significantly in insulin-sensitive but not insulin-resistant subjects. MIP-1{alpha} was undetectable in serum. Conclusion: Insulin regulation of CCL2 differs between insulin-sensitive and resistant subjects in a direction which could exacerbate adipose tissue inflammation.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.